Highline Capital Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-222,776
| Closed | -$3.97M | – | 31 |
|
|
2020
Q1 | $3.97M | Sell |
222,776
-626,702
| -74% | -$11.2M | 0.97% | 21 |
|
|
2019
Q4 | $28.3M | Sell |
849,478
-27,642
| -3% | -$922K | 4.49% | 14 |
|
|
2019
Q3 | $20.9M | Sell |
877,120
-136,958
| -14% | -$3.26M | 3.05% | 15 |
|
|
2019
Q2 | $36.4M | Buy |
1,014,078
+27,200
| +3% | +$978K | 2.67% | 18 |
|
|
2019
Q1 | $36.5M | Buy |
986,878
+525,200
| +114% | +$19.4M | 2.29% | 20 |
|
|
2018
Q4 | $19.9M | Buy |
461,678
+129,778
| +39% | +$5.59M | 1.33% | 24 |
|
|
2018
Q3 | $15.7M | Hold |
331,900
| – | – | 0.73% | 27 |
|
|
2018
Q2 | $16.5M | Sell |
331,900
-44,923
| -12% | -$2.24M | 0.55% | 31 |
|
|
2018
Q1 | $18.7M | Sell |
376,823
-23,077
| -6% | -$1.15M | 0.64% | 28 |
|
|
2017
Q4 | $14.9M | Sell |
399,900
-10,100
| -2% | -$376K | 0.49% | 29 |
|
|
2017
Q3 | $12.9M | Sell |
410,000
-15,300
| -4% | -$482K | 0.37% | 29 |
|
|
2017
Q2 | $7.68M | Buy |
+425,300
| New | +$7.68M | 0.24% | 32 |
|